Skip to Content

9 3 5510 (Mercaptopurine 50 mg)

Pill with imprint 9 3 5510 is Yellow, Round and has been identified as Mercaptopurine 50 mg. It is supplied by Teva Pharmaceuticals USA.

Mercaptopurine is used in the treatment of acute lymphoblastic leukemia and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Mercaptopurine 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 9 3 5510

Mercaptopurine 50 mg 9 3 5510
Mercaptopurine 50 mg 9 3 5510 Front
Mercaptopurine 50 mg 9 3 5510 Back
Mercaptopurine 50 mg 9 3 5510
Mercaptopurine 50 mg 9 3 5510

Mercaptopurine

Imprint
9 3 5510
Strength
50 mg
Color
Yellow
Size
9.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Antimetabolites
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
National Drug Code (NDC)
00093-5510
Inactive Ingredients
corn starch, potato starch, lactose, magnesium stearate, stearic acid

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.